Crossmark

Prevalence of HIV-1 drug resistance amongst newly diagnosed HIV-infected infants age 4–8 weeks, enrolled in three nationally representative PMTCT effectiveness surveys, South Africa: 2010, 2011–12 and 2012–13

Crossref DOI link: https://doi.org/10.1186/s12879-019-4339-y

Published Online: 2019-09-16

Published Print: 2019-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Hunt, Gillian M.

Ledwaba, Johanna

Salimo, Anna

Kalimashe, Monalisa

Dinh, Thu-Ha

Jackson, Debra

Sherman, Gayle

Puren, Adrian

Ngandu, Nobubelo K.

Lombard, Carl

Morris, Lynn

Goga, Ameena
License Information

Text and Data Mining valid from 2019-09-01

Version of Record valid from 2019-09-16
More Information

Article History

First Online: 16 September 2019

Ethics approval and consent to participate

: Ethical approval was obtained through the Ethics Committee at the South African Medical Research Council and by approval for the research was granted by the Centers for Disease Control and Prevention, Atlanta. The resistance testing and analysis was approved by the Human Research Ethics Committee (Medical) at the University of the Witwatersrand, Johannesburg.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below